Skip to main content

FY2023 NIH awards · Principal investigators

Pathology at Cedars-Sinai Medical Center

Los Angeles, CA

Funding
$2.9M
$2,949,416
Awards
5
FY2023 NIH awards in Pathology
Principal investigators
4
4 lead a grant here, 0 co-investigators
Department rank
#60
of 93 · Ranking
  • NIH names only the principal investigators on an award, so this page lists only them. The department is the award's: it is where ScienceDex counts the award, not a list of the department's members.
  • NIH gives hospital awards no department code. Each counts under its contact PI's own department, from their PubMed affiliations, or under a department inferred from the award's topic when no affiliation names one. Each award below says which. How departments are assigned
  • These are the awards in the Pathology row of the Cedars-Sinai Medical Center page. It is part of Cedars-Sinai Health System's Pathology.

Leads a grant in this department

4 contact PIs of these awards, by the funding they lead. Other principal investigators on an award are listed with it and under Co-investigators.

  1. Dorfleutner, Andrea

    Leads 2 awards · $1,391,703

    • 5R01AI165797-02Department: investigator's affiliation
      A novel mechanism for NLRP3 inflammasome activation in human macrophages
      $765,715
      award amount
    • 5R01AI134030-05Department: investigator's affiliation
      A novel essential inflammasome component propagating inflammatory responses
      $625,988
      award amount
  2. Jorth, Peter Allan

    Leads 1 award · $573,835

    • 5R01AI146425-04Department: investigator's affiliation
      Molecular mechanisms of hypervirulence in antibiotic-resistant Pseudomonas aeruginosa
      $573,835
      award amount
  3. Bernstein, Kenneth E

    Leads 1 award · $566,378

    • 5R01AI164519-02Department: investigator's affiliation
      ACE and myeloid cell metabolism
      $566,378
      award amount
  4. Gibb, David R

    Leads 1 award · $417,500

    • 5R01HL165169-02Department: investigator's affiliation
      Autoantibody-induced type 1 interferons and RBC alloimmunization in sickle cell disease
      $417,500
      award amount